Robert Walker

Robert Walker is a seasoned finance professional specializing in healthcare equities. Currently serving as a Senior Analyst at Point72 since January 2023, Walker previously held analyst positions at Redline Capital and Curam Capital Management from 2020 to 2022 and 2017 to 2020, respectively, focusing on research within the healthcare sector. Walker's earlier experience includes roles at HSBC Global Banking and Markets as an Investment Banking Analyst in Healthcare M&A, BNP Paribas in FIG, and Barclays as a Risk Analyst. Walker's foundation in finance began with a summer analyst position at ING. Academically, Walker holds an MSc in Molecular Medicine from Imperial College London and a BSc (Hons) in Human Physiology from the University of Leeds.